Ford's trailing-12-month dividend yield is around 4.5%, while Pfizer's is around 6.9%.

One reason why many investors could be asking this question is Pfizer's high dividend payout ratio of 99.4%. This metric ...

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

It might take a while longer, but Pfizer is on the path to recovery. Is 2026 the year Pfizer (NYSE: PFE) finally turns things ...

More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Pfizer enters the new year as a company in transition, but one with a heavily fortified bottom line. Management has set a revenue floor of approximately $61 billion for 2026. This is a realistic, ...

Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...

By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...

Initiatives from former President Joe Biden and current President Donald Trump have been effective in reducing the prices of ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...